Carmel Pharma/PhaSeal Exhibiting at Booth #2818 at ASHP MCM
Offerings Include Personalized Cost Savings Demonstrations, Blue Man Group Ticket Giveaways and More
Columbus, OH, November 22, 2009 --(PR.com)-- Carmel Pharma, manufacturer of the PhaSeal System for the safe handling of hazardous drugs, will offer several activities during the 44th Annual ASHP Midyear Clinical Meeting, including interactive, personalized demonstrations showing how PhaSeal can provide significant cost savings in pharmacy.
“Recent, independent, peer-reviewed, published data shows that using PhaSeal could substantially lower your oncology drug spend. Just how much it can save is different in every situation,” says David S. Schneider, President of Carmel Pharma, Inc. “This year at ASHP, we’ll be able to give attendees a baseline idea of how PhaSeal can contribute to cost savings in their own pharmacies while still offering the clinically proven protection they’d expect from PhaSeal, the Gold Standard.”
Visitors to the booth will also have the chance to win tickets to see Blue Man Group during their time in Las Vegas. One of the most critically acclaimed theatrical productions on the Las Vegas Strip, Blue Man Group has been described as “visually stunning,” “wildly inventive” and “hysterically funny.”
The 44th Annual ASHP Midyear Clinical Meeting will be held in Las Vegas, NV at the Sands Convention Center Sunday, December 6, through Thursday, December 10. Exhibit days/hours are Monday, December 7, and Tuesday, December 8, from 11am-3pm and Wednesday, December 9, from 11am-2pm.
PhaSeal is more than a system for the safe handling of hazardous drugs. It’s the only clinically proven closed-system drug transfer device (CSTD) available today and is validated by more than 10 independent, peer-reviewed, published clinical studies. Distinguished by prominent thought leaders as the “Gold Standard” in safe handling, PhaSeal’s airtight Expansion Chamber and leakproof Double Membrane connections prevent exposure to hazardous drugs, including aerosols and vapors, and make it the only system that meets the National Institute for Occupational Safety and Health (NIOSH) and International Society of Oncology Pharmacy Practitioners (ISOPP) definition of a true CSTD. Its streamlined design and universally-compatible components make the system easy to use from preparation and administration to waste disposal.
The PhaSeal System is manufactured by Carmel Pharma AB in Gothenburg, Sweden and is distributed from its U.S. affiliate office, Carmel Pharma, Inc., in Columbus, OH. PhaSeal has been in use in the United States since 2000 and implemented in more than 1000 cancer facilities, infusion centers and private practices, including M.D. Anderson and Texas Children’s in Houston, TX; City of Hope in Duarte, CA; Dana Farber Cancer Institute in Boston, MA; SwedishAmerican Hospital in Rockford, IL; and Johns Hopkins University in Baltimore, MD, just to name a few. For more information on Carmel Pharma or the PhaSeal System, please visit www.phaseal.com or email info@carmelpharmausa.com. To request additional product details, high-resolution imagery, story ideas and expert references, or to learn more about the topic of safe handling from today’s clinical thought leaders, please contact Emily Frydendal at 614-318-2635 or emily.frydendal@carmelpharma.com.
###
“Recent, independent, peer-reviewed, published data shows that using PhaSeal could substantially lower your oncology drug spend. Just how much it can save is different in every situation,” says David S. Schneider, President of Carmel Pharma, Inc. “This year at ASHP, we’ll be able to give attendees a baseline idea of how PhaSeal can contribute to cost savings in their own pharmacies while still offering the clinically proven protection they’d expect from PhaSeal, the Gold Standard.”
Visitors to the booth will also have the chance to win tickets to see Blue Man Group during their time in Las Vegas. One of the most critically acclaimed theatrical productions on the Las Vegas Strip, Blue Man Group has been described as “visually stunning,” “wildly inventive” and “hysterically funny.”
The 44th Annual ASHP Midyear Clinical Meeting will be held in Las Vegas, NV at the Sands Convention Center Sunday, December 6, through Thursday, December 10. Exhibit days/hours are Monday, December 7, and Tuesday, December 8, from 11am-3pm and Wednesday, December 9, from 11am-2pm.
PhaSeal is more than a system for the safe handling of hazardous drugs. It’s the only clinically proven closed-system drug transfer device (CSTD) available today and is validated by more than 10 independent, peer-reviewed, published clinical studies. Distinguished by prominent thought leaders as the “Gold Standard” in safe handling, PhaSeal’s airtight Expansion Chamber and leakproof Double Membrane connections prevent exposure to hazardous drugs, including aerosols and vapors, and make it the only system that meets the National Institute for Occupational Safety and Health (NIOSH) and International Society of Oncology Pharmacy Practitioners (ISOPP) definition of a true CSTD. Its streamlined design and universally-compatible components make the system easy to use from preparation and administration to waste disposal.
The PhaSeal System is manufactured by Carmel Pharma AB in Gothenburg, Sweden and is distributed from its U.S. affiliate office, Carmel Pharma, Inc., in Columbus, OH. PhaSeal has been in use in the United States since 2000 and implemented in more than 1000 cancer facilities, infusion centers and private practices, including M.D. Anderson and Texas Children’s in Houston, TX; City of Hope in Duarte, CA; Dana Farber Cancer Institute in Boston, MA; SwedishAmerican Hospital in Rockford, IL; and Johns Hopkins University in Baltimore, MD, just to name a few. For more information on Carmel Pharma or the PhaSeal System, please visit www.phaseal.com or email info@carmelpharmausa.com. To request additional product details, high-resolution imagery, story ideas and expert references, or to learn more about the topic of safe handling from today’s clinical thought leaders, please contact Emily Frydendal at 614-318-2635 or emily.frydendal@carmelpharma.com.
###
Contact
Carmel Pharma, Inc.
Emily Frydendal
614-318-2635
www.carmelpharma.com
Emily Frydendal
614-318-2635
www.carmelpharma.com
Contact
Categories